PHATHOM PHARMACEUTICALS, INC. (PHAT) Net income 2018–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$221.2MFY2025 · since FY2018: -$1.3M → -$221.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$221.2M | +33.8% |
| FY2024 | -$334.3M | -65.8% |
| FY2023 | -$201.6M | -2.0% |
| FY2022 | -$197.7M | -37.4% |
| FY2021 | -$143.9M | -11.5% |
| FY2020 | -$129.1M | +49.4% |
| FY2019 | -$255.1M | -19708.3% |
| FY2018 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net marginPHAT Gross profitPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →